Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07371728
PHASE4

Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

View on ClinicalTrials.gov

Summary

This project is being carried out to study the use of a medication to reduce nausea and vomiting after ear surgery.

Official title: Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery: A Pilot Randomized-Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-06-01

Completion Date

2028-06-01

Last Updated

2026-01-28

Healthy Volunteers

No

Interventions

DRUG

Aprepitant

Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. Oral aprepitant of 80mg will be administered within an hour of induction for an otological surgery.

OTHER

Placebo

Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. An oral placebo capsule will be administered within an hour of induction for an otological surgery.

Locations (1)

Jewish General Hospital

Montreal, Quebec, Canada